Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Wex preparing IND for Tectin

Nov. 25, 2005

Preliminary results from phase I study of IPL-455903

Nov. 25, 2005

Xyrem approved to treat excessive daytime sleepiness in narcolepsy patients

Nov. 24, 2005

Enrollment begins in phase III Viprinex study for ischemic stroke

Nov. 24, 2005

Phase III Oxytrex results in moderate to severe osteoarthritic pain

Nov. 24, 2005

ChemoCentryx seeks clearance to begin clinical studies of CCX-915

Nov. 24, 2005

First patient enrolled in European phase III trial of Alzhemed

Nov. 24, 2005

Curcumin and its metabolite highlighted as promising agents for neurologic disorders

Nov. 24, 2005

Antipsychotic effects of a new 5-HT2C receptor agonist from Pfizer

Nov. 24, 2005

RN-624 reduces pain due to knee osteoarthritis

Nov. 23, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...